Lisata Therapeutics Inc (LSTA)

[akasidney86]

Don't know who listened to the presentation, but why they don't want to divulge even a glimpse of what they see in terms of costs is very disappointing. Fear is always worse than reality, and really, sitting now at.40 cents, how much worse can it be? As in Washington, the coveruup is worse than the crime. I was also disappointed that they didn't even mention what their enrolled patient load was, and some important, to not say humane, decisions needed for those patients.

I agree with all of their decisions, hard as they are to hear. Going for an OS final endpoint in a rapidly evolving clinical environment was always a risk, and with the advent of checkpoint inhibitors, proved the $30-40 million needed to finish it to risky. I also believe that a major reason they pulled the plug is simply that they couldn't get patients given the improved treatment options available to the sick.

In any event, what's the point of selling at this point. Maybe at the end of the year for tax loss, and lots can happen between now and then. I always liked the idea of a biotech backed up by a plowhorse... looks like the horse is now firmly in front of the cart!